Effects of Facial Topical Lidocaine on Serum Levels of Lidocaine and MEG-X
Funded on Sep 5, 2011
Status: Funded
Researcher(s):
Jeffrey M. Kenkel, MD, FACS
Grant Name:
Interim Research Grant
Amount Awarded:
$28,874
Project Name:
Effects of Facial Topical Lidocaine on Serum Levels of Lidocaine and MEG-X
Project Summary:
Topical lidocaine is applied liberally in clinics and spas throughout the world. Despite this, there is little to no data describing the safe doses, toxicity, and clinical guidelines regarding the topical use of lidocaine, particularly in a highly vascularized area such as the face. The primary purpose is to examine the metabolism of 4% topical lidocaine (LMX-4) to determine peak serum levels, and common clinical treatment variables affecting absorption, as a means of increasing patient safety.
Related Projects
- Published on Apr 27, 2021Breast implant illness (BII) is a term used to describe physical and psychological symptoms experienced by some women following breast implant surgery. Few studies have examined the experiences of women with BII—a poorly understood condition with no...
- Published on Apr 19, 2020In 2017, the ASERF Gluteal Fat Grafting Task Force reported gluteal fat grafting to be a high-risk procedure and recommended specific surgical techniques to decrease the risk of pulmonary fat embolism (PFE).
- Published on Oct 1, 2019Deaths in gluteal autografting occur due to gluteal vein injuries, but data are lacking on the precise location and caliber of these veins.